NO950733L - Fremgangsmåte for isolering og rensing av proteiner som er avhengig av vitamin K - Google Patents

Fremgangsmåte for isolering og rensing av proteiner som er avhengig av vitamin K

Info

Publication number
NO950733L
NO950733L NO950733A NO950733A NO950733L NO 950733 L NO950733 L NO 950733L NO 950733 A NO950733 A NO 950733A NO 950733 A NO950733 A NO 950733A NO 950733 L NO950733 L NO 950733L
Authority
NO
Norway
Prior art keywords
vitamin
isolating
purifying protein
protein dependent
dependent
Prior art date
Application number
NO950733A
Other languages
English (en)
Other versions
NO322372B1 (no
NO950733D0 (no
Inventor
Bernhard Fischer
Artur Mitterer
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO950733D0 publication Critical patent/NO950733D0/no
Publication of NO950733L publication Critical patent/NO950733L/no
Publication of NO322372B1 publication Critical patent/NO322372B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19950733A 1994-02-28 1995-02-27 Fremgangsmate for separasjon av et vitamin K-avhengig protein fra ikke-vitamin K-avhengige, medfolgende proteiner fra en proteinholdig losning NO322372B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4406515A DE4406515C1 (de) 1994-02-28 1994-02-28 Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine

Publications (3)

Publication Number Publication Date
NO950733D0 NO950733D0 (no) 1995-02-27
NO950733L true NO950733L (no) 1995-08-29
NO322372B1 NO322372B1 (no) 2006-09-25

Family

ID=6511421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19950733A NO322372B1 (no) 1994-02-28 1995-02-27 Fremgangsmate for separasjon av et vitamin K-avhengig protein fra ikke-vitamin K-avhengige, medfolgende proteiner fra en proteinholdig losning

Country Status (13)

Country Link
US (1) US5633350A (no)
EP (1) EP0669342B1 (no)
JP (1) JPH07258286A (no)
AT (1) ATE205218T1 (no)
CA (1) CA2143510C (no)
CZ (1) CZ290471B6 (no)
DE (1) DE4406515C1 (no)
DK (1) DK0669342T3 (no)
ES (1) ES2161790T3 (no)
FI (1) FI116526B (no)
HU (1) HU219828B (no)
NO (1) NO322372B1 (no)
SK (1) SK22695A3 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE299889T1 (de) * 1998-04-15 2005-08-15 Novo Nordisk As Neues verfahren zur trennung von proteinen unter verwendung eines ca++ enthaltenden elutionsmittels
WO2002008249A1 (fr) * 2000-07-21 2002-01-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Procede de purification de la proteine de liaison a l'ion calcium
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
US9187549B2 (en) * 2004-12-23 2015-11-17 Novo Nordisk Healthcare A/G Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
DE602006015907D1 (de) * 2005-01-14 2010-09-16 Bayer Healthcare Llc Verfahren zur reinigung von factor vii
EP1877037A2 (en) * 2005-04-28 2008-01-16 Novo Nordisk Health Care AG A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
WO2007101681A1 (en) 2006-03-07 2007-09-13 Baxter International Inc Highly phosphorylated and sulfated recombinant factor ix
WO2008104372A1 (en) * 2007-02-28 2008-09-04 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
CN102939299B (zh) * 2010-01-18 2016-04-20 诺沃—诺迪斯克保健股份有限公司 凝血因子的纯化
CA2797614A1 (en) 2010-04-29 2011-11-03 Baxter International Inc. Purification method for divalent cation binding proteins on anion exchange resin
CN103459417B (zh) 2011-02-01 2018-04-10 诺沃—诺迪斯克有限公司 胰岛素的纯化
AU2012322949B2 (en) * 2011-10-14 2015-07-02 Takeda Pharmaceutical Company Limited Protein purification by anion exchange chromatography
PL2748179T3 (pl) * 2011-10-14 2022-04-11 Takeda Pharmaceutical Company Limited Oczyszczanie białka metodą anionowej chromatografii jonowymiennej
NZ629845A (en) * 2013-03-15 2016-10-28 Baxalta Inc Purification method for vitamin k dependent proteins by anion exchange chromatography

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
AT395596B (de) * 1991-06-20 1993-01-25 Immuno Ag Verfahren zur herstellung von aktiviertem protein c

Also Published As

Publication number Publication date
CA2143510C (en) 1999-12-21
EP0669342B1 (de) 2001-09-05
ES2161790T3 (es) 2001-12-16
HUT72844A (en) 1996-05-28
CA2143510A1 (en) 1995-08-29
HU219828B (hu) 2001-08-28
FI950888A0 (fi) 1995-02-27
CZ53995A3 (en) 1995-09-13
ATE205218T1 (de) 2001-09-15
DE4406515C1 (de) 1995-10-19
JPH07258286A (ja) 1995-10-09
EP0669342A2 (de) 1995-08-30
HU9500594D0 (en) 1995-04-28
SK22695A3 (en) 1995-09-13
NO322372B1 (no) 2006-09-25
FI950888A (fi) 1995-08-29
DK0669342T3 (da) 2001-11-12
FI116526B (fi) 2005-12-15
CZ290471B6 (cs) 2002-07-17
US5633350A (en) 1997-05-27
EP0669342A3 (de) 1997-04-16
NO950733D0 (no) 1995-02-27

Similar Documents

Publication Publication Date Title
NO950733L (no) Fremgangsmåte for isolering og rensing av proteiner som er avhengig av vitamin K
DE3586944D1 (de) Vorrichtung zum abtrennen von halbleiterscheiben.
NO863191D0 (no) Fremgangsmaate for individualisering av baerbare hjelpeinnretninger, saasom kort.
DE3850503D1 (de) Zusammenbauverfahren und -vorrichtung für Nockenwellen.
DE3584667D1 (de) Universales prozesssteuerungsgeraet und -verfahren.
NO882205L (no) Fjaerbue for sentrering.
DE3676032D1 (de) Aufhaengungsregelungsvorrichtung.
NO861084L (no) Fremgangsmaate og anordning for forflytting av loggeverktoey i avviksbroenner.
DE3861383D1 (de) Kraftschrauber zum zweistufigen festziehen von schraubverbindungen.
DE58900310D1 (de) Luftleitvorrichtung zum kuehlen von radbremsen.
NO863765L (no) Arylmetylazoler og salter derav samt fremgangsmaate til fremstilling derav.
DE3673609D1 (de) Aufzeichnungsgeraet und aufzeichnungsverfahren.
DE3675870D1 (de) Aufhaengungsregelungsvorrichtung.
EP0544644A3 (en) Method for judging the correctness or incorrectness of prospective contour points of an irradiation field
DE3672030D1 (de) Halbleitervorrichtung und methode zu deren herstellung.
DE3685563D1 (de) Vorrichtung zum abspielen von videoplatten.
DE3780018D1 (de) Methode zum scheiden und ueberfuehren eines ionenaustauscherharzes.
KR890004983A (ko) 실리카겔 입자의 제조 방법
IT8323152A0 (it) Dispositivo di registrazione e centraggio per servofreni.
FI844034A0 (fi) Foerfarande foer framstaellning av nya 4-klor-furo-(3,4-c)-pyridinderivat.
FI902468A0 (fi) Foerfarande foer isolering av antimon fraon sura loesningar som innehaoller det.
DE3382123D1 (de) Halbleiteranordnung und herstellungsverfahren.
EP0196277A3 (en) Coordinator device for diets
NO861057L (no) Direktkoplet (on-line) verifisering av videofremvisningsgenerator.
SU903802A1 (ru) Регул тор

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees